Attività
Vendite per attività
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Biologics and Therapeutic Device Incubator
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -71,86% |
Vendite per regione
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -71,86% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 53 | 08/01/19 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 04/02/19 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 15/06/20 |
William E. Horne
BRD | Director/Board Member | 70 | 09/10/18 |
Jason Assad
IRC | Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 65 | 17/01/22 | |
Chief Executive Officer | 53 | 08/01/19 | |
William E. Horne
BRD | Director/Board Member | 70 | 09/10/18 |
Chairman | 77 | 08/01/19 | |
Matthew Anderer
BRD | Director/Board Member | 59 | 17/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 712 710 | 253 876 ( 35,62 %) | 0 | 35,62 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+12,85% | 229 Mrd | |
+13,88% | 195 Mrd | |
+18,39% | 142 Mrd | |
+28,78% | 109 Mrd | |
+1,67% | 64,85 Mrd | |
+18,24% | 54,33 Mrd | |
+7,04% | 52,09 Mrd | |
+10,83% | 45,15 Mrd | |
+5,94% | 37,39 Mrd |